Experimental analysis shows wogonin's neuroprotective effect against LPS-induced inflammation in BV-2 cells, suggesting possible benefits for neurodegenerative diseases.
Key Points
Wogonin effectively reduced IL-6 and IL-1β levels in BV-2 cells exposed to LPS, promoting neuroprotection.
Treatment with wogonin restored tyrosine hydroxylase expression in SH-SY5Y neurons after LPS-induced injury.
Immunohistochemical and immunofluorescence staining confirmed the neuroprotective effects of wogonin in neuronal cultures.
Findings indicate wogonin could offer therapeutic avenues targeting inflammation in Parkinson's disease.